Eterna Therapeutics posts August 2023 investor presentation; no material news disclosed

Ernexa Therapeutics Inc.

Item 7.01 furnished new investor presentation (Exhibit 99.1) with no specific financial results or corporate events.
Presentation available on company website; filing does not contain earnings, guidance, or operational updates.
No material changes, transactions, or forward-looking statements identified in the furnished exhibit.
Routine disclosure intended to update investor materials without new material information.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.